Content about Nervous system

May 4, 2012
Sleep aid solutions

According to Biotab Nutraceuticals chief marketing officer Robert Wilhovsky, there is seasonality within sleep aids. Biotab fielded the No. 3 sleep aid Alteril in food, drug and mass (without Walmart) with dollar growth of more than 126% for the 12 weeks ended April 15, according to SymphonyIRI Group data. Drug Store News caught up with Wilhovsky to talk about how Biotab approaches the overall sleep category, and how the company helps drive its sleep aid solution through key selling periods.

May 2, 2013
More than 80% of mothers regularly experience pain, survey finds

The vast majority of mothers experience pain throughout their bodies, according to a new survey.

March 18, 2013
Galena buys rights to cancer-pain drug from Orexo

Galena Biopharma has purchased rights to a treatment for breakthrough cancer pain from a Swedish drug maker, Galena said Monday.

November 15, 2012
OTC use on rise as self-care trend grows

Over-the-counter medications continue to gain in popularity among consumers, who — whether as a matter of cost savings or convenience — are increasingly turning to OTCs to treat their conditions, including both acute, episodic conditions like the common cold and such chronic conditions as frequent pain and allergy. 


June 21, 2012
FDA approves Lyrica for spinal pain

The Food and Drug Administration has approved a new indication for a Pfizer drug.

April 18, 2012
Bayer returning to pain relief heritage with Bayer Aspirin Fast Relief Challenge

To encourage consumers to rethink aspirin for pain relief — according to a recent Bayer survey, only 8% of respondents reported taking aspirin more often that other OTC pain relievers — Bayer on Tuesday issued the Fast Relief Challenge and is giving away 100,000 bottles of Bayer Advanced Aspirin so consumers can put the pain reliever to the test.

April 12, 2012
Impax Labs files Gralise patent challenge

Generic drug maker Impax Labs is challenging the patent protection on a drug used to treat postherpetic neuralgia, the company said Thursday.

January 25, 2012
NARB upholds Advil's challenge of Excedrin's faster-relief claims

The National Advertising Review Board on Tuesday recommended that Novartis Consumer Health discontinue advertising claims that the company’s Excedrin Extra Strength product starts relieving headache pain faster than Advil.

January 24, 2012
Oxecta now commercially available

A pain medication that utilizes Acura Pharmaceuticals' Aversion technology now is commercially available.

November 16, 2011
Sam's Club donates $1 million to help end child hunger

Sam's Club announced that it will donate $1 million to support child hunger programs through Feeding America as part of its Holiday Taste of Sam's Club event, which will be held from Nov. 18 to 20.

October 17, 2011
Archimedes Pharma launches Lazanda for breakthrough cancer pain

Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

October 10, 2011
Depomed launches shingles drug

Depomed has launched a new drug for treating shingles, the drug maker said Monday.

October 4, 2011
Amneal launches generic Felbatol

Amneal last month launched its version of an epilepsy treatment.

July 12, 2011
Nonprescription migraine med study to be presented at Headache Update Conference

PuraMed BioScience on Monday announced that headache researcher Roger Cady will be exhibiting a poster presentation of his independent clinical study of PuraMed's nonprescription migraine medication LipiGesic-M at the 2011 Headache Update Conference being held in Orlando, Fla., July 14 to 17.

June 22, 2011
Pfizer, Acura get FDA OK for Oxecta

The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.

June 3, 2011
Once again, Kroger emphasizes hunger awareness

Kroger has kicked off a two-week campaign that is expected to generate $5 million dollars in cash and food donations to assist 80 local food banks in communities where Kroger's customers and associates live and work.

May 19, 2011
CHPA praises FDA committees' decision to mandate weight-based dosing of APAP for children

Two Food and Drug Administration advisory committees on Wednesday unanimously voted in favor of mandating weight-based dosing for children between the ages of 2 and 12 years who are being administered acetaminophen.

April 4, 2011
ProStrakan announces U.S. launch of Abstral

A drug used to treat pain in cancer patients now is available in the United States.

March 16, 2011
Sensa For Men arrives at GNC

Sensa Products on Wednesday announced the expansion of its product line with Sensa For Men exclusively through GNC.

March 7, 2011
Pain Relief

The OTC Pain Relief Ingredient Guide breaks down the indication, active ingredients, purpose and dosage of OTC internal and external analgesics.

February 28, 2011
Matrix Labs' gabapentin capsules get FDA OK

The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.

February 18, 2011
Burn cream tackles pain, infection, scars

Welmedix’s First Degree therapeutic burn cream provides a unique solution for minor burns that the company suggests is an unmet need at retail. It’s an all-in-one burn cream that helps soothe pain, cool the burn, prevent infection and reduce the appearance of scars.


January 19, 2011
Food Should Taste Good launches online contest

Food Should Taste Good has launched the Touchdown Dance-Off contest, giving fans a chance to win $10,000.

January 10, 2011
Abstral OKed as breakthrough pain treatment for cancer patients

The Food and Drug Administration has approved a new drug for treating pain in cancer patients, the agency said Friday.

November 4, 2010
FDA approves Cymbalta for treating chronic musculoskeletal pain

The Food and Drug Administration has approved a new usage for a drug used to...

© 2013 Drug Store News. All Rights Reserved.